A Phase 1 Study To Investigate Cln-049, A Flt3/Cd3 Bispecific T Cell Engager, In Patients With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (Aml) Or Myelodysplastic Syndrome (Mds)
CLN-049
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1 Study To Investigate Cln-049, A Flt3/Cd3 Bispecific T Cell Engager, In Patients With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (Aml) Or Myelodysplastic Syndrome (Mds) ### Output: CLN-049